Quality & Testing Every Semaglutide batch is manufactured to exceed 99% purity and tested using HPLC and LC-MS protocols through an ISO 17025-accredited laboratory, confirming identity, potency, and batch-to-batch consistency
Summary: Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) that, based on Phase 2 trial data, produces significant appetite suppression and progressive weight loss, alongside gastrointestinal side effects that are most prominent during dose escalation
With semaglutide GLP-1, the first hormone-based weight loss medication of its kind, a new generation of safe, effective weight loss medications is now available
Whichever method you use, be sure to first remove all personal information on the prescription label or use a permanent marker to cover it